Scarica l'app Stockscreener
44.97
3.95%
-1.85
Precedente Chiudi:
$46.82
Aprire:
$47
Volume 24 ore:
10,251
Relative Volume:
0.29
Capitalizzazione di mercato:
$275.00M
Reddito:
-
Utile/perdita netta:
$-7.12M
Rapporto P/E:
-19.55
EPS:
-2.3
Flusso di cassa netto:
$-6.82M
1 W Prestazione:
-3.25%
1M Prestazione:
+40.88%
6M Prestazione:
+8.47%
1 anno Prestazione:
+6,766%
Intervallo 1D:
$44.37
$47.00
Intervallo di 1 settimana:
$44.26
$48.35
Portata 52W:
$0.3438
$54.30
Monopar Therapeutics Inc Stock (MNPR) Company Profile
Nome
Monopar Therapeutics Inc
Settore
Industria
Telefono
(847) 388-0349
Indirizzo
1000 SKOKIE BLVD SUITE 350, WILMETTE
Confronta MNPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
44.97 | 286.31M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-23 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-19 | Ripresa | Piper Sandler | Overweight |
| 2025-01-10 | Iniziato | Piper Sandler | Overweight |
| 2024-10-11 | Iniziato | Rodman & Renshaw | Buy |
| 2021-01-28 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Monopar Therapeutics Inc Borsa (MNPR) Ultime notizie
What drives Monopar Therapeutics Inc. stock priceAccelerated capital growth - PrintWeekIndia
Is Monopar Therapeutics Inc. a good long term investmentPhenomenal returns - Autocar Professional
Does Monopar Therapeutics Inc. stock pay reliable dividendsConsistent double returns - jammulinksnews.com
What analysts say about Monopar Therapeutics Inc. stockFree Stock Index Interpretation - Autocar Professional
Monopar Therapeutics Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Long Term Trading Analysis for (MNPR) - news.stocktradersdaily.com
Is TBMCR a good long term investmentExplosive trading opportunities - jammulinksnews.com
Technical Analysis: Sreeleathers Limited (535601)Tremendous portfolio expansion - jammulinksnews.com
Is Siddhi Acquisition Corp. Debt Equity Composite Units a good long term investmentMarket-crushing profits - jammulinksnews.com
Las Vegas Sands Corp. Stock Analysis and ForecastMassive wealth growth - jammulinksnews.com
Best Stocks for Risk Averse Investors Market Trend Prediction ToolsFree Stock Chart Pattern Guide - jammulinksnews.com
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Institutional Investors Control 29% of Monopar Therapeutics Inc. (NASDAQ:MNPR) and Were Rewarded Last Week After Stock Increased 23% - 富途牛牛
When is the best time to buy Monopar Therapeutics Inc. stockFree Professional Portfolio Management - Newser
What analysts say about Monopar Therapeutics Inc. stock outlook5x Profit Potential - Newser
Why Monopar Therapeutics Inc. stock attracts strong analyst attentionProfit Focused Trade Alerts - beatles.ru
Monopar therapeutics director Tsuchimoto sells $356k in stock By Investing.com - Investing.com Canada
Monopar therapeutics director Starr sells $672k in stock By Investing.com - Investing.com Canada
Monopar therapeutics CEO Chandler Robinson sells $672k in stock By Investing.com - Investing.com Canada
Monopar Therapeutics Executives Buy and Sell Shares Amid Recent Volatility. - AInvest
how monopar therapeutics inc. stock performs during market volatilityFree Day Trading Recommendations - Newser
How Monopar Therapeutics Inc. stock performs during market volatilityFree Low-Risk Investment Plans - Newser
What makes Monopar Therapeutics Inc. stock price move sharplyAnalyst Grade Signals - Newser
Monopar Therapeutics Inc Azioni (MNPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Monopar Therapeutics Inc Azioni (MNPR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| STARR CHRISTOPHER M | Director |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
5,173 |
| Robinson Chandler | Chief Executive Officer |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
73,472 |
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):